(Q27851578)

English

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

13 November 2016

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial (English)

1 reference

13 November 2016

0 references

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

Eric Van Cutsem

2

object named as

Eric Van Cutsem

0 references

Hyun Cheol Chung

1 reference

ORCID Public Data File 2021

Denis Ulises Landaverde

1 reference

ORCID Public Data File 2021

1

object named as

Yung-Jue Bang

0 references

8

object named as

Atsushi Ohtsu

0 references

author name string

Andrea Feyereislova

3

0 references

Hyun C Chung

4

0 references

Lin Shen

5

0 references

Akira Sawaki

6

0 references

Florian Lordick

7

0 references

Yasushi Omuro

9

0 references

Taroh Satoh

10

0 references

Giuseppe Aprile

11

0 references

Evgeny Kulikov

12

0 references

Julie Hill

13

0 references

Michaela Lehle

14

0 references

Josef Rüschoff

15

0 references

Yoon-Koo Kang

16

0 references

language of work or name

0 references

publication date

28 August 2010

0 references

0 references

376

0 references

687-97

0 references

9742

0 references

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab--mechanism of action and use in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of HER2 gene amplification by fluorescence in situ hybridization and concordance with the clinical trials immunohistochemical assay in women with metastatic breast cancer evaluated for treatment with trastuzumab

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961121-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27851578&oldid=1777450736"